Ocular Nanotechnology Darluniad Clawr Cylchgrawn by Cynthia Turner

Ocular Nanotechnology Darluniad Clawr Cylchgrawn by Cynthia Turner is a highly esteemed winner of the very prestigious 2024 Gwobr Haearn A' Design Award in Graffeg Cyfrifiadurol Competition Category.

HaearnGraffeg Cyfrifiadurol· 2024

Ocular Nanotechnology Darluniad Clawr Cylchgrawn

by Cynthia Turner

Client: Alexander and Turner Medical Illustration Studio

Gwobr Haearn A' Design Award Winner in Graffeg Cyfrifiadurol Category

34,530

Verified Award Winner

Verify Award Status for #154797

Visit Site View at A' Design Award Press Release Award Badge

Colors

The Design

About Ocular Nanotechnology Darluniad Clawr Cylchgrawn

Fel endidau o fyd arall, mae'r mecanweithiau dosbarthu bychain hyn yn rhyfeddol yn eu hamrywiaeth o siapiau a strwythurau, a hefyd yn eu perthynas â'r amgylchedd dyfrlyd y gallant symud ynddo i ddosbarthu eu llwythi yn ddeallus i'r cyrchfan gywir. Nanoronynau yw'r nanocludwyr mwyaf cyffredin ar gyfer therapiwteg llygadol oherwydd eu biogydnawsedd a'u gallu i gael eu llwytho â chyffuriau a therapïau genynnol trwy atodiad cemegol, mewnblannu, neu gapsiwleiddio yn y nanocludydd. Yn glocwedd gan ddechrau am hanner dydd: nanopolymer, nanoemwlsiwn, nanomisel, a liposom.

The Recognition

About the Gwobr Haearn A' Design Award

Mae Ocular Nanotechnology Darluniad Clawr Cylchgrawn yn enillydd Gwobr Haearn A' Design Award, cydnabyddiaeth fawreddog a roddir i ddyluniadau da sydd yn bodloni'r gofynion proffesiynol a diwydiannol a ddisgwylir gan greadigaethau wedi'u dylunio'n dda. Mae enillwyr Haearn yn dangos medrusrwydd mawr, arbenigedd uchel, dealltwriaeth arbenigol a gallu creadigol eu crewyr. Disgwylir i Ocular Nanotechnology Darluniad Clawr Cylchgrawn fod yn greadigaeth uchel ei bri, a edmygir ac a anwylir, sydd yn ymarferol ac yn arloesol. Mae'r dyluniad buddugol hwn o Wobr Haearn A' Design Award yn integreiddio arferion gorau'r diwydiant ac mae ganddo nodweddion technegol cymwys wedi'u cysylltu â gwybodaeth ymarferol a dawn. Parchir Ocular Nanotechnology Darluniad Clawr Cylchgrawn am ei drylwyredd ac fe'i dyluniwyd i ddarparu gwelliannau ansawdd bywyd sydd yn helpu i wneud y byd yn lle gwell.

Behind the Design

Press Kit

Credits, team members and technical details provided by the designer.

Unique Properties: Nanoparticles are 1 to 100 nanometres in diameter and have unique properties due to their small size and high surface area to volume ratio. Nanoparticles are the most common nanocarriers for ocular therapeutics due to their biocompatibility and their capacity to be loaded with drugs and gene therapies by chemical attachment, embedment, or encapsulation in the nanocarrier. Highlighting four types of nanotechnology-based ocular drug delivery systems delivering their payloads to the back of the eye, clockwise starting at noon: nanopolymer, nanoemulsion, nanomicelle, and liposome.
Dimensions & Packaging: Width 431.8 mm width x Height 279.4 mm, 300 dpi, tiff
Tags: medical illustration, biomedical artist, visual science, ophthamology, nanocarriers, ocular drug delivery
Production Technology: Created using Cinema 4D, a 3D modeling program, 3D Models, and hand-painting in Photoshop, using a stylus and tablet on a Mac.
Design Challenge: Create accurate depictions of ocular drug delivery nanocarriers and arrange the four carriers in a pleasing composition that did not necessarily give one precedence in importance over another.
Research: The artist researched the morphology of the 4 specified nanocarriers and created accurate scientific visualizations of them. Each nanocarrier was separately modeled and imaged in a 3D program, and then brought into a Photoshop document. The composited tiff was finished by handpainting in Photoshop to reflect light from one element to the next to bring color harmony to the palette. Additional motion elements were painted to tie the composition together and lead the eye in reading the image.
Inspiration: An illustration for the cover of EyeNet, the magazine of the American Academy of Ophthalmology, for their annual meeting and special annual issue. I created the nanocarriers individually in Cinema4D, a 3D software program, and then composed them in Photoshop on a background of a field of the rods and cones cells found at the back of the eye. I enhanced the rendered 3D models by reflecting the colors from one into the other, and creating light effects to add movement and excitement to the composition.
Project Duration: The project was in development for two weeks at the artist's studio in Santa Rosa Beach, Florida, USA.
Operation Flow: The Art Director requested an illustration with a science fiction futuristic feel to be used for their special annual issue, which is also released on the occasion of the American Academy of Ophthalmology's annual meeting and is used to brand the meeting.
Patents: Copyrights belong to Cynthia Turner, 2023
Image Credits: Image #1: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #2: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #3: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #4: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #5: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023